Key result
Multimodality imaging with echo, CMR, and cardiac CT optimizes assessment and management of HCM.
This review highlights the complementary roles and limitations of echocardiography, cardiac MRI, and cardiac CT in the comprehensive evaluation and management of hypertrophic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
Synthesizes evidence supporting multimodality imaging in HCM; leaves open optimal integration and outcome validation.
Hypertrophic cardiomyopathy (HCM) is characterized by pathologic hypertrophy in the absence of a potentially causative disease process and carries increased risk of heart failure, atrial fibrillation, and sudden cardiac death. Synergistic use of multi-modal imaging is pivotal and necessary in the diagnosis and management of patients with, or at risk for, HCM. Echocardiography, cardiac MR, and cardiac computed tomography each have important roles and limitations in assessing the morphologic changes responsible for symptoms and morbidity in HCM. In this article, we will explore these modalities and their roles in evaluating HCM.
No takes yet. Share an insight, caveat, or question.
Cutts et al. (2026) conducted a review in Hypertrophic cardiomyopathy (HCM). Multimodality imaging (echocardiography, cardiac MR, cardiac computed tomography) was evaluated. Multimodality imaging using echocardiography, cardiac MR, and cardiac CT is pivotal for assessing morphologic changes and managing patients with hypertrophic cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: